Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence
A Nigerian pharmaceutical company, Fidson Healthcare Plc, has been selected to develop and manufacture a generic version of baloxavir marboxil, an antiviral medicine used to treat influenza. The selection makes Fidson one of 11 manufacturers across nine countries chosen under a voluntary licensing a...
Sentiment: Positive (
0.40
)
Bias: Neutral
Fact-Checked Information
Source:
Google Fact Check Tools
Reliability:
Unknown
Notes:
No fact-checks found for this content
Verified on Oct 04, 2026